Villanueva C, Balanzó J
Department of Gastroenterology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Drugs. 1997 Mar;53(3):389-403. doi: 10.2165/00003495-199753030-00004.
In patients with acute haemorrhage from peptic ulcers, emergency endoscopy should be performed as soon as safely possible after resuscitation to detect the bleeding lesion, to define stigmata of recent haemorrhage, and to perform endoscopic therapy when required. Subsequent management will be determined by the results of diagnostic endoscopy. Ulcers with a clean base or with flat blood spots will not require endoscopic therapy: the patient can be discharged early after resuscitation and the institution of treatment to promote ulcer healing. Ulcers in which endoscopy discloses active arterial bleeding or a nonbleeding visible vessel should be treated, as these signs denote a high risk of an unfavourable outcome, and the efficacy of endoscopic therapy has been demonstrated when these signs are identified. In keeping with the available data, antisecretory therapy, vasoconstrictor drugs and tranexamic acid cannot be recommended as treatment for an acute ulcer bleeding episode. On the other hand, it has been shown in controlled trials that endoscopic therapy significantly reduces the incidence of further bleeding and the requirement for emergency surgery in patients with ulcers with active arterial bleeding or a nonbleeding visible vessel. Meta-analyses of these studies have also shown a significant decrease in mortality with endoscopic therapy. Among the available endoscopic methods for haemostasis, injection therapy is a valid choice since its efficacy has been similar to that of thermal methods in comparative studies, while its simplicity, tolerability and low cost are great advantages. A second endoscopic treatment can be attempted in patients with further haemorrhage after the initial endoscopic therapy, and permanent haemostasis can be achieved in half of these cases. However, the decision to perform this second endoscopic treatment should be taken individually, as the routine use of such a procedure could increase mortality by delaying surgery.
对于患有消化性溃疡急性出血的患者,应在复苏后尽快安全地进行急诊内镜检查,以检测出血病变,确定近期出血的征象,并在需要时进行内镜治疗。后续治疗将根据诊断性内镜检查的结果来决定。基底清洁或有平坦血斑的溃疡不需要内镜治疗:患者在复苏和开始促进溃疡愈合的治疗后可早期出院。内镜检查发现有活动性动脉出血或可见非出血血管的溃疡应进行治疗,因为这些征象表明预后不良的风险很高,而且当发现这些征象时,内镜治疗的疗效已得到证实。根据现有数据,不推荐将抑酸治疗、血管收缩药物和氨甲环酸作为急性溃疡出血发作的治疗方法。另一方面,对照试验表明,内镜治疗可显著降低有活动性动脉出血或可见非出血血管的溃疡患者再次出血的发生率以及急诊手术的需求。对这些研究的荟萃分析也表明,内镜治疗可显著降低死亡率。在现有的内镜止血方法中,注射疗法是一种有效的选择,因为在比较研究中其疗效与热凝方法相似,同时其操作简单、耐受性好且成本低是其巨大优势。对于初次内镜治疗后仍有出血的患者,可尝试进行第二次内镜治疗,其中一半的病例可实现永久性止血。然而,是否进行第二次内镜治疗应个体化决定,因为常规使用这种方法可能会因延迟手术而增加死亡率。